Impact of primary staging with fibroblast activation protein specific enzyme inhibitor (FAPI)-PET/CT on radio-oncologic treatment planning of patients with esophageal cancer

Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radio...

Full description

Saved in:
Bibliographic Details
Main Authors: Ristau, Jonas (Author) , Giesel, Frederik L. (Author) , Häfner, Matthias (Author) , Staudinger, Fabian (Author) , Lindner, Thomas (Author) , Merkel, Andreas (Author) , Schlittenhardt, Joel (Author) , Kratochwil, Clemens (Author) , Choyke, P. L. (Author) , Herfarth, Klaus (Author) , Debus, Jürgen (Author) , Haberkorn, Uwe (Author) , Körber, Stefan A. (Author)
Format: Article (Journal)
Language:English
Published: 5 October 2020
In: Molecular imaging & biology
Year: 2020, Volume: 22, Issue: 6, Pages: 1495-1500
ISSN:1860-2002
DOI:10.1007/s11307-020-01548-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11307-020-01548-y
Get full text
Author Notes:J. Ristau, F.L. Giesel, M.F. Haefner, F. Staudinger, T. Lindner, A. Merkel, J. Schlittenhardt, C. Kratochwil, P.L. Choyke, K. Herfarth, J. Debus, U. Haberkorn, S.A. Koerber
Description
Summary:Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radiotherapy planning as a first clinical analysis.
Item Description:Gesehen am 18.10.2021
Physical Description:Online Resource
ISSN:1860-2002
DOI:10.1007/s11307-020-01548-y